Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-054015
Filing Date
2006-03-15
Accepted
2006-03-14 21:57:09
Documents
9
Period of Report
2006-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 912258
2 MASTER AGREEMENT RELATING TO THE PRODUCTION OF CLARIFIED GOAT'S MILK dex1021.htm EX-10.21 126663
3 MANUFACTURING AGREEMENT BY AND BETWEEN GTC AND MERRIMACK PHARMACEUTICALS, INC. dex1022.htm EX-10.22 195159
4 EXECUTIVE COMPENSATION DISCLOSURE SCHEDULE dex1030.htm EX-10.30 15425
5 LIST OF SUBSIDIARIES dex21.htm EX-21 4603
6 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex23.htm EX-23 2265
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 9815
8 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 9809
9 CERTIFICATION OF CHIEF EXECUTIVE AND FINANCIAL OFFICER PURSUANT TO SECTION 906 dex32.htm EX-32 5364
  Complete submission text file 0001193125-06-054015.txt   1282762
Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GTC BIOTHERAPEUTICS INC (Filer) CIK: 0000904973 (see all company filings)

EIN.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0103
Type: 10-K | Act: 34 | File No.: 000-21794 | Film No.: 06686615
SIC: 2836 Biological Products, (No Diagnostic Substances)